Speaker illustration

Miss Mounira Kharoubi

Creteil (France)

Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cancer/Cardiotoxicity

Session: Comorbodities

Thumbnail